Nuvation Bio Inc. Class A Common Stock (NY:NUVB)

4.850 -0.030 (-0.61%)

Delayed Quote Updated: 12:57 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nuvation Bio Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

Nuvation Bio And 3 Other Stocks Under $4 Insiders Are Buying ↗

September 22, 2023

The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

August 03, 2023

From Nuvation Bio Inc.

Via Business Wire

Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board

June 01, 2023

From Nuvation Bio Inc.

Via Business Wire

Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

May 04, 2023

From Nuvation Bio Inc.

Via Business Wire

Analyst Expectations for Nuvation Bio's Future ↗

March 24, 2023

Via Benzinga

Where Nuvation Bio Stands With Analysts ↗

March 24, 2023

Via Benzinga

After FDA Hold, Nuvation Bio Stops NUV-422 Cancer Development Program ↗

August 01, 2022

Via Benzinga

Short Volatility Alert: Nuvation Bio Inc. ↗

July 11, 2022

On Friday, shares of Nuvation Bio Inc. (NYSE: NUVB) experienced volatile short activity. After the activity, the stock price went up +0% to $4.04. The overall sentiment for NUVB has been Bearish.

Via Benzinga

The 7 Worst Stocks to Buy Now ↗

March 18, 2023

With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now.

Via InvestorPlace

Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

March 15, 2023

From Nuvation Bio Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗

January 06, 2023

Via Benzinga

Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868

December 19, 2022

From Nuvation Bio Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

November 18, 2022

On Friday, 64 companies achieved new lows for the year.

Via Benzinga

FDA Institutes Partial Hold On Nuvation Bio's Early-Stage Solid Tumor Trial - Read Why ↗

June 27, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 16, 2022

On Wednesday, 70 companies set new 52-week lows.

Via Benzinga

Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update

November 03, 2022

From Nuvation Bio Inc.

Via Business Wire

Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson ↗

August 22, 2022

UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading.

Via Benzinga

Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update

August 04, 2022

From Nuvation Bio Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

August 03, 2022

Wednesday's session saw 51 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗

August 02, 2022

Upgrades

Via Benzinga

Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development Program

August 01, 2022

From Nuvation Bio Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

July 22, 2022

During Friday's session, 61 companies made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

August 01, 2022

On Monday, 92 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 18, 2022

Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 28, 2022

On Thursday, 108 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 25, 2022

On Monday, 100 companies reached new 52-week lows.

Via Benzinga

Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer

July 18, 2022

From Nuvation Bio Inc.

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Nuvation Bio Inc. with Losses of $100,000 to Contact the Firm

June 30, 2022

From The Schall Law Firm

Via Business Wire

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Nuvation Bio Inc. with Losses of $100,000 to Contact the Firm

June 29, 2022

From The Schall Law Firm

Via Business Wire

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies ↗

June 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.